vs
Side-by-side financial comparison of Enpro Inc. (NPO) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $295.4M, roughly 1.0× Enpro Inc.). Bio-Techne runs the higher net margin — 12.8% vs -10.8%, a 23.7% gap on every dollar of revenue. On growth, Enpro Inc. posted the faster year-over-year revenue change (14.3% vs -6.4%). Over the past eight quarters, Enpro Inc.'s revenue compounded faster (7.1% CAGR vs 4.2%).
Enpro is a US-based industrial technology company that designs and manufactures products and materials for technology-intensive sectors. The company serves industries such as semiconductors, aerospace, power generation, heavy-duty trucking, agricultural machinery, chemical processing, pulp and paper, and life sciences from 61 primary manufacturing facilities located in 12 countries, worldwide. It is organized under three segments: Sealing Technologies, Advanced Surface Technologies, and Engin...
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
NPO vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $295.4M | $295.9M |
| Net Profit | $-32.0M | $38.0M |
| Gross Margin | 42.1% | 64.6% |
| Operating Margin | 11.2% | 18.4% |
| Net Margin | -10.8% | 12.8% |
| Revenue YoY | 14.3% | -6.4% |
| Net Profit YoY | -330.2% | 68.3% |
| EPS (diluted) | $-1.50 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $295.4M | $295.9M | ||
| Q3 25 | $286.6M | — | ||
| Q2 25 | $288.1M | $317.0M | ||
| Q1 25 | $273.2M | $316.2M | ||
| Q4 24 | $258.4M | $297.0M | ||
| Q3 24 | $260.9M | $289.5M | ||
| Q2 24 | $271.9M | $306.1M | ||
| Q1 24 | $257.5M | $303.4M |
| Q4 25 | $-32.0M | $38.0M | ||
| Q3 25 | $21.6M | — | ||
| Q2 25 | $26.4M | $-17.7M | ||
| Q1 25 | $24.5M | $22.6M | ||
| Q4 24 | $13.9M | $34.9M | ||
| Q3 24 | $19.8M | $33.6M | ||
| Q2 24 | $26.7M | $40.6M | ||
| Q1 24 | $12.5M | $49.1M |
| Q4 25 | 42.1% | 64.6% | ||
| Q3 25 | 41.9% | — | ||
| Q2 25 | 43.3% | 62.7% | ||
| Q1 25 | 43.3% | 67.9% | ||
| Q4 24 | 42.3% | 65.3% | ||
| Q3 24 | 42.3% | 63.2% | ||
| Q2 24 | 43.8% | 66.4% | ||
| Q1 24 | 41.2% | 67.4% |
| Q4 25 | 11.2% | 18.4% | ||
| Q3 25 | 14.3% | — | ||
| Q2 25 | 15.9% | -7.5% | ||
| Q1 25 | 15.3% | 12.2% | ||
| Q4 24 | 12.5% | 16.0% | ||
| Q3 24 | 13.1% | 13.8% | ||
| Q2 24 | 17.7% | 15.0% | ||
| Q1 24 | 10.9% | 22.1% |
| Q4 25 | -10.8% | 12.8% | ||
| Q3 25 | 7.5% | — | ||
| Q2 25 | 9.2% | -5.6% | ||
| Q1 25 | 9.0% | 7.1% | ||
| Q4 24 | 5.4% | 11.7% | ||
| Q3 24 | 7.6% | 11.6% | ||
| Q2 24 | 9.8% | 13.3% | ||
| Q1 24 | 4.9% | 16.2% |
| Q4 25 | $-1.50 | $0.24 | ||
| Q3 25 | $1.01 | — | ||
| Q2 25 | $1.25 | $-0.11 | ||
| Q1 25 | $1.15 | $0.14 | ||
| Q4 24 | $0.65 | $0.22 | ||
| Q3 24 | $0.94 | $0.21 | ||
| Q2 24 | $1.27 | $0.26 | ||
| Q1 24 | $0.59 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $114.7M | $172.9M |
| Total DebtLower is stronger | $655.3M | $260.0M |
| Stockholders' EquityBook value | $1.5B | $2.0B |
| Total Assets | $2.7B | $2.5B |
| Debt / EquityLower = less leverage | 0.42× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.7M | $172.9M | ||
| Q3 25 | $132.9M | — | ||
| Q2 25 | $107.1M | $162.2M | ||
| Q1 25 | $240.3M | $140.7M | ||
| Q4 24 | $236.3M | $177.5M | ||
| Q3 24 | $206.9M | $187.5M | ||
| Q2 24 | $175.9M | $152.9M | ||
| Q1 24 | $163.9M | $145.3M |
| Q4 25 | $655.3M | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | $640.1M | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | $644.9M | $389.0M |
| Q4 25 | $1.5B | $2.0B | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | $1.9B | ||
| Q1 25 | $1.5B | $2.0B | ||
| Q4 24 | $1.4B | $2.1B | ||
| Q3 24 | $1.5B | $2.1B | ||
| Q2 24 | $1.4B | $2.1B | ||
| Q1 24 | $1.4B | $2.0B |
| Q4 25 | $2.7B | $2.5B | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.4B | $2.6B | ||
| Q1 25 | $2.5B | $2.6B | ||
| Q4 24 | $2.5B | $2.7B | ||
| Q3 24 | $2.5B | $2.7B | ||
| Q2 24 | $2.5B | $2.7B | ||
| Q1 24 | $2.5B | $2.7B |
| Q4 25 | 0.42× | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | 0.45× | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | 0.46× | 0.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NPO
| Sealing Technologies Segment | $187.0M | 63% |
| General Industrial | $71.3M | 24% |
| Power Generation | $19.9M | 7% |
| Oiland Gas Market | $15.0M | 5% |
| Semiconductors | $2.2M | 1% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
